Open AccessReasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Author(s) -
Mirko Sikirica,
Antonio Jiménez Martín,
Robert Wood,
Andrea Leith,
James Piercy,
Victoria Higgins
Publication year - 2017
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s141235
Subject(s) - discontinuation , medicine , nausea , weight loss , diabetes mellitus , type 2 diabetes , family medicine , vomiting , pediatrics , obesity , endocrinology
Nonadherence to glucagon-like peptide-1 receptor agonists (GLP1 RAs) is relatively common among patients with type 2 diabetes mellitus (T2DM). This study sought to identify reasons why patients discontinue GLP1 RAs.